{"id":470765,"date":"2026-02-12T19:19:09","date_gmt":"2026-02-12T19:19:09","guid":{"rendered":"https:\/\/www.newsbeep.com\/ca\/470765\/"},"modified":"2026-02-12T19:19:09","modified_gmt":"2026-02-12T19:19:09","slug":"novo-nordisk-plans-wegovy-vials-amid-obesity-drug-competition","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ca\/470765\/","title":{"rendered":"Novo Nordisk plans Wegovy vials amid obesity-drug competition"},"content":{"rendered":"<p>    <img fetchpriority=\"high\" decoding=\"async\" src=\"https:\/\/www.newsbeep.com\/ca\/wp-content\/uploads\/2026\/02\/a42763c6679526251c544c66685c260f.jpeg\" alt=\"Novo Nordisk plans Wegovy vials amid obesity-drug competition\" loading=\"eager\" height=\"557\" width=\"960\" class=\"yf-lglytj  loaded\"\/> Novo Nordisk plans Wegovy vials amid obesity-drug competition Proactive uses images sourced from Shutterstock      <\/p>\n<p class=\"yf-vbsvxt\"><a href=\"https:\/\/finance.yahoo.com\/quote\/NVO\" data-ylk=\"slk:Novo Nordisk (NYSE:NVO);elm:context_link;itc:0;sec:content-canvas\" class=\"link \" rel=\"nofollow noopener\" target=\"_blank\">Novo Nordisk (NYSE:NVO)<\/a> announced that it is planning to introduce its weight-loss medication Wegovy in vials.<\/p>\n<p class=\"yf-vbsvxt\">\u201cWe are exploring various device presentations for Wegovy, including vials\u2014some are launching this year, others are coming in the future,\u201d the company said.<\/p>\n<p class=\"yf-vbsvxt\">Currently, Wegovy is available in both injectable and oral forms.<\/p>\n<p class=\"yf-vbsvxt\">The move follows rival Eli Lilly, which began offering vials of the two lowest doses of its weight-loss drug Zepbound in 2024. Last year, Lilly reduced prices for Zepbound vials and expanded the range of doses available online.<\/p>\n<p class=\"yf-vbsvxt\">Zepbound overtook Wegovy in US prescriptions during 2025, marking a challenging period for Novo Nordisk. The company\u2019s plan to introduce vials is seen as part of its effort to regain market share in the competitive obesity-drug sector.<\/p>\n<p class=\"yf-vbsvxt\">Shares of Novo Nordisk traded down 0.9% on Thursday at about $48, down about 5% so far this year.<\/p>\n","protected":false},"excerpt":{"rendered":"Novo Nordisk plans Wegovy vials amid obesity-drug competition Proactive uses images sourced from Shutterstock Novo Nordisk (NYSE:NVO) announced&hellip;\n","protected":false},"author":2,"featured_media":470766,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[33],"tags":[49,48,9949,84,377,5246,191594,13600],"class_list":["post-470765","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-ca","tag-canada","tag-eli-lilly","tag-health","tag-medication","tag-novo-nordisk","tag-vials","tag-weight-loss-drug"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/470765","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/comments?post=470765"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/470765\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media\/470766"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media?parent=470765"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/categories?post=470765"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/tags?post=470765"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}